COVID-19: Professor Omura talks: Possibility of Ivermectin
COVID-19:
Bunshun Online: Interview
Nobel Prize Scientist Satoshi Omura talked about the “unexpected potential of “antiparasitic drugs””.
Ivermectin:
Kitasato University Special Emeritus Professor Satoshi Omura contributed to the development.
In 2015, Mr. Omura received the Nobel Prize in Physiology or Medicine for his discovery of a new treatment for infectious diseases caused by nematodes.
It is recognized for the development of the specific drug ivermectin, which has eliminated various endemic diseases in the tropics.
Monthly magazine in Japan: “Bungei Shunju” July issue
Mr. Omura responded to an interview in the July issue of “Bungeishunju” and shared his impressions when he touched the first report.
The names of the new coronavirus treatments such as “Remdecivir” and “avigan” are currently in use.
Mr. Omura says that it is important to keep an eye on the clinical trial status of the COVID-19 therapeutic drug.
To be honest, I’m not so surprised by this news.
Surprising possibilities of “antiparasitic drugs”:
Ivermectin was originally a parasite control drug.
Since 2012, it has become clear that “it is effective against HIV and dengue fever.”
As a result of in vitro (in vitro test), it has been found that “it is also effective against a group of viruses (generally called flaviviruses).”
The new coronavirus is also a type of flavivirus
The goals of the therapeutic drug:
It’s about making medicines that are scientifically proven to be effective without side effects.
When it comes to the new coronavirus, it may be used by millions of people.
If you don’t have all the evidence and data, you can’t use it because you’re scared.
Bunshun online